Molecular Diagnostics
Molecular Diagnostics and Therapy LLP began its mission in 2017, aiming to transform patient care through advanced diagnostics. Today, we proudly operate NABH-accredited Nuclear Medicine and Radiology centers in India, delivering comprehensive services from X-ray to Gamma scans, Radionuclide Therapies to PET CT, and a fully automated state-of-the-art NABL Lab capable of processing 10,000 tubes daily.
Serving over 200,000 patients annually across functional imaging, cross-sectional imaging, and pathology, we’ve consistently grown and innovated:
We launched our first exclusive Nuclear Medicine Center in Ghaziabad, Western UP’s pioneer facility offering PET/CT, Gamma Camera, and Radionuclide Therapy (High/Low Dose). Today, this center serves over 100,000 patients a year, including 18,000 patients accessing Nuclear Medicine services.
We expanded our diagnostic capacity in Ghaziabad to include full-fledged radiology services, further strengthening integrated patient care.
As we expand and innovate, these key milestones mark our dedication to quality diagnostics and patient-centered care.
Inaugurated our modern Nuclear Medicine facility in North-East Delhi, now the region’s largest. Performing 10,000+ PET CT scans annually and processing 30,000+ Onco Pathology cases each year.
Acquired National Imaging & Pathlabs in South-West Delhi, now a cutting-edge center serving 60,000+ patients annually from Delhi and Haryana.
Opened our third Nuclear Medicine Facility in South Delhi with advanced digital PET technology. Designed for 15,000 PET patients and 100,000 Onco Pathology patients annually.
Pioneering diagnostic healthcare across India with technology, scale, and compassion.
Noida Expansion
Gwalior Expansion
Dehradun Expansion
Meerut Expansion
At Molecular, we now handle over 150 PET/CT/SPECT patients daily, setting industry benchmarks with up to 1250+ scans per PET/CT machine annually.
Our team of 200+ professionals includes 20 full-time onsite doctors, pathologists, and radiologists from India’s top institutes.
With a nationwide network of online reporting specialists, we ensure timely, quality diagnostics even during high-demand scenarios.
Molecular Diagnostics operates with AI-enabled automation suites, adapting to future healthcare needs—united by a commitment to affordable, patient-centric diagnostics.
Driven by vision, empowered by expertise
Distinguished Nuclear Medicine specialist & visionary leader
Together, Dr. Nikunj Jain have combined medical expertise, technology leadership, and operational excellence to shape Molecular Diagnostics and Therapy LLP into a trusted, innovative, and patient-first diagnostics brand growing across Delhi NCR and multiple cities across India.